UnknownNot Applicable

A Study of AARC Standards on Diagnosis and Treatment of Patients With HBV-ACLF in China (AARC China Study)

China3,000 participantsStarted 2019-07-02

Plain-language summary

The AARC China Study is to establish a widely recognized and harmonized standard of patients with HBV-ACLF in the Asia Pacific region.

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. development of new ascites within 4 weeks or re-emergence of ascites who have previous well controlled ascites (greater than or equal to grade 2 or 3; International ascites club criteria)
✓. development of hepatic encephalopathy
✓. development of gastrointestinal hemorrhage
✓. development of jaundice (serum bilirubin greater than or equal to 3mg/dl)
✓. development of bacterial infection

Non-liver transplant mortality

Timeframe: 30 days, 90 days

NCT IDNCT04054037

SponsorQin Ning

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-01

Qin Ning, MD., PhD.